DOCSLIB.ORG

Narcolepsy Caused by Acute Disseminated Encephalomyelitis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Narcolepsy Caused by Acute Disseminated Encephalomyelitis OBSERVATION Narcolepsy Caused by Acute Disseminated Encephalomyelitis Richard F. Gledhill, MD, MRCP; Peter R. Bartel, PhD; Yasushi Yoshida, MD, PhD; Seiji Nishino, MD, PhD; Thomas E. Scammell, MD Background: Narcolepsy with cataplexy is caused by ueduct, which are consistent with acute disseminated a selective loss of hypocretin-producing neurons, but nar- encephalomyelitis. colepsy can also result from hypothalamic and rostral brainstem lesions. Results: After treatment with steroids, this patient’s sub- jective sleepiness, hypersomnia, and hypocretin defi- Patient: We describe a 38-year-old woman with severe ciency partially improved. daytime sleepiness, internuclear ophthalmoplegia, and bilateral delayed visual evoked potentials. Her multiple Conclusions: Autoimmune diseases such as acute dis- sleep latency test results demonstrated short sleep laten- seminated encephalomyelitis can produce narcolepsy. cies and 4 sleep-onset rapid eye movement sleep peri- Most likely, this narcolepsy is a consequence of demy- ods, and her cerebrospinal fluid contained a low con- elination and dysfunction of hypocretin pathways, but centration of hypocretin. Magnetic resonance imaging direct injury to the hypocretin neurons may also occur. showed T2 and fluid-attenuated inversion recovery hy- perintensity along the walls of the third ventricle and aq- Arch Neurol. 2004;61:758-760 ARCOLEPSY IS CHARAC- REPORT OF A CASE terized by excessive daytime sleepiness and rapid eye movement A previously healthy, 38-year-old, black, (REM) sleep-related South African woman was admitted to Ga- Nsymptoms such as cataplexy. More than Rankuwa Hospital, Pretoria, Republic of 90% of people with narcolepsy with cata- South Africa, with 6 weeks of severe day- plexy have no detectable hypocretin/ time sleepiness and hypersomnia (total orexin in their cerebrospinal fluid sleep time about 16 of every 24 h). She re- (CSF),1,2 most likely because of a loss of ported forgetfulness and impaired vision but hypocretin-producing neurons.3,4 denied cataplexy, sleep paralysis, hypna- Because narcolepsy usually occurs spo- gogic hallucinations, a preceding viral in- radically in individuals positive for fection, fever, rash, or vaccination. Her body From the Department of human leukocyte antigen DQB1*0602, mass index was increased at 32.3 kg/m2. She Neurology, Medical University of Southern Africa, an autoimmune process is hypothesized was disoriented to time and place, and she Ga-Rankuwa Hospital, to injure the hypocretin neurons. was inattentive and had impaired memory. Pretoria, Republic of South Although the evidence for an inflamma- Visual acuity was 20/300 OD and 20/150 Africa (Dr Gledhill); the tory process is sparse, many have won- OS, and the pupils were 4 mm, with a weak Department of Neurology, dered whether autoimmune disorders reaction to light. She had bilateral inter- University of Pretoria and such as multiple sclerosis or acute dis- nuclear ophthalmoplegia with poor up- Pretoria Academic Hospital, seminated encephalomyelitis (ADEM) gaze and convergence. Cerebrospinal fluid Pretoria (Dr Bartel); the Center could cause narcolepsy.5-9 had no white blood cells, a normal glu- for Narcolepsy, Department of We describe an unusual patient with cose level, 44 mg/dL protein, and a nor- Psychiatry, Stanford secondary narcolepsy due to ADEM whose mal IgG index. Her morning cortisol level University, Stanford, Calif (Drs Yoshida and Nishino); and sleepiness was associated with sleep- was 8 µg/dL (221 nmol/L; normal range, the Department of Neurology, onset REM (SOREM) periods and a low 9-22 µg/dL [248-607 nmol/L]). Beth Israel Deaconess Medical CSF concentration of hypocretin that par- Electroencephalography performed Center, Boston, Mass tially improved along with her subjective while the patient was awake showed fron- (Dr Scammell). sleepiness. tal intermittent delta activity, a slow al- (REPRINTED) ARCH NEUROL / VOL 61, MAY 2004 WWW.ARCHNEUROL.COM 758 ©2004 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/29/2021 pha rhythm, and excessive theta activity. Magnetic reso- A nance imaging revealed multiple areas of T2 and fluid- attenuated inversion recovery hyperintensity involving the corona radiata and deep periventricular gray matter. This region of increased signal intensity was especially prominent around the third ventricle and aqueduct, in- volving most of the hypothalamus (Figure) and extend- ing rostrally to the basal forebrain. Scattered regions of contrast enhancement were evident throughout the hy- pothalamus, especially near the fornix. Rapid plasma re- agin, serum angiotensin-converting enzyme, human im- munodeficiency virus antibodies, autoantibody panel, and liver and thyroid function test results were all normal. She was positive for human leukocyte antigens DR2 and DQB1*0602. The unextracted hypocretin-1 level in CSF was low (87 pg/mL [24.4 pmol/L]; normal, Ͼ200 pg/mL [56.1 pmol/L]).1 On the basis of these laboratory results and her monophasic onset of symptoms, ADEM was di- agnosed, and the patient was treated with high-dose ste- roids. Magnetic resonance imaging 1 month later showed B smaller, fewer lesions. Six months after her initial examination, the pa- tient’s subjective sleepiness was partially improved, but she still took 3 to 4 nonrefreshing naps per day, each last- ing as long as an hour. Although she continued to have mildly impaired memory and visual acuity, with slight slowing of visual evoked potentials, her extraocular move- ments and attention were normal. Her multiple sleep la- tency test results demonstrated an average sleep latency of 4.4 minutes and SOREM periods in all 4 naps. The CSF hypocretin-1 level (148 pg/mL [41.5 pmol/L]) had in- creased to the intermediate range.1 On the basis of these test results and her persistent sleepiness, narcolepsy with- out cataplexy was diagnosed. The patient’s sleepiness par- tially responded to methylphenidate hydrochloride. One year after her initial examination, some sleepi- ness persisted, with a total daily sleep time of 12 hours without methylphenidate hydrochloride. Overnight poly- somnography results showed 7.6 hours of sleep with a sleep efficiency of 95%, REM latency of 52 minutes, 20% Coronal fluid-attenuated inversion recovery magnetic resonance images stage 1 sleep, normal proportions of all other stages, and demonstrate increased signal intensity in the hypothalamus, particularly near no sleep-disordered breathing. The multiple sleep la- the walls of the third ventricle (A) and in the corona radiata, floor of the tency test results were essentially unchanged, with an av- aqueduct, and raphe nuclei (B). erage sleep latency of 2.6 minutes and SOREM periods in 4 of 5 naps. cess of white blood cells, as in this case. The patient’s Peptides are most stable when frozen, but samples monophasic onset of symptoms with bilateral delayed vi- could be maintained only at ambient temperature dur- sual evoked potentials, internuclear ophthalmoplegia, and ing the 9 days of shipping from the Republic of South periventricular T2 hyperintensity makes ADEM the most Africa to the United States. Therefore, CSF also was ana- likely diagnosis, especially because multiple sclerosis is lyzed from 3 patients with other neurologic diseases (2 extremely rare among black South Africans. with motor neuron disease and 1 with spastic dysphonia). Because demyelinating diseases and narcolepsy may These specimens were collected within a few weeks of be caused by an autoimmune or neurodegenerative pro- our patient’s first lumbar puncture and shipped to- cess, many clinicians have taken a special interest in cases gether with this first sample. Hypocretin levels for the of narcolepsy associated with multiple sclerosis or ADEM. control subjects were all in the normal range (241-290 Hypersomnia and low hypocretin levels were reported pg/mL [67.6-81.4 pmol/L).1 in a girl with ADEM and a young woman with multiple sclerosis, but neither had SOREM periods or cata- 10,11 COMMENT plexy. In other cases of multiple sclerosis with nar- colepsy, it is usually unclear whether the narcolepsy was We describe a patient with narcolepsy and low hypocre- caused by a focal lesion.5-9 The inflammatory lesions in tin levels due to ADEM. Although most patients with our patient clearly involved the hypothalamic regions in ADEM have CSF lymphocytosis, a few may have no ex- which hypocretin neurons are found and extended into (REPRINTED) ARCH NEUROL / VOL 61, MAY 2004 WWW.ARCHNEUROL.COM 759 ©2004 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/29/2021 state-regulatory, hypocretin-responsive areas in the mid- Nishino, and Scammell); obtained funding (Drs Nishino brain and pons such as the raphe nuclei. In addition, her and Scammell); administrative, technical, and material sup- sleepiness was coincident with her ADEM. Thus, we think port (Drs Bartel, Yoshida, Nishino, and Scammell); study it is most likely that ADEM caused her narcolepsy, es- supervision (Drs Gledhill and Scammell). pecially because her hypocretin level and subjective sleepi- This study was supported by grants MH62589 and ness partially improved after treatment with steroids. MH01507 from the National Institutes of Health, Bethesda, Unlike previous patients with hypersomnia due to Md. ADEM, our patient had SOREM periods, possibly be- Corresponding author: Thomas E. Scammell, MD, De- cause she is DQB1*0602 positive, and these individuals partment of Neurology, Beth Israel
Load more

Recommended publications
  • The Neurobiology of Narcolepsy-Cataplexy
    Progress in Neurobiology Vol. 41, pp. 533 to 541, 1993 0301-0082/93/$24.00 Printed in Great Britain. All rights reserved © 1993 Pergamon Press Ltd THE NEUROBIOLOGY OF NARCOLEPSY-CATAPLEXY MICHAEL S. ALDRICH Department of Neurology, Sleep Disorders Center, University of Michigan Medical Center, Ann Arbor, MI, U.S.A. (Received 17 July 1992) CONTENTS 1. Introduction 533 2. Clinical aspects 533 2.1. Sleepiness and sleep attacks 533 2.2. Cataplexy and related symptoms 534 2.3. Clinical variants 534 2.3.1. Narcolepsy without cataplexy 534 2.3.2. Idiopathic hypersomnia 534 2.3.3. Symptomatic narcolepsy 534 2.4. Treatment 534 3. Pathophysiology 535 4. Neurobiological studies 535 4.1. The canine model of narcolepsy 535 4.2. Pharmacology of human cataplexy 537 4.3. Postmortem studies 537 5. Genetic and family studies 537 6. Summary and conclusions 539 References 539 1. INTRODUCTION 2. CLINICAL ASPECTS Narcolepsy is a specific neurological disorder Narcolepsy has a prevalence that varies worldwide characterized by excessive sleepiness that cannot be from as little as 0.0002% in Israel to 0.16% in Japan; fully relieved with any amount of sleep and by in North America and Europe the prevalence is about abnormalities of rapid eye movement (REM) 0.03-0.06% (Dement et al., 1972; Honda, 1979; Lavie sleep. About two-thirds of patients also have brief and Peled, 1987). The onset of narcoleptic symptoms, episodes of muscle weakness usually brought on by usually in the second or third decade of life, may emotion, referred to as cataplexy. The disorder gener- occur over a few days or weeks or it may be so ally begins in adolescence and continues throughout gradual that the loss of full alertness is unrecognized life.
    [Show full text]
  • Sleep Disorders Preeti Devnani
    SPECIAL ISSUE 1: INVITED ARTICLE Sleep Disorders Preeti Devnani ABSTRACT Sleep disorders are an increasingly important and relevant burden faced by society, impacting at the individual, community and global level. Varied presentations and lack of awareness can make accurate and timely diagnosis a challenge. Early recognition and appropriate intervention are a priority. The key characteristics, clinical presentations and management strategies of common sleep disorders such as circadian rhythm disorders, restless legs syndrome, REM behavior disorder, hypersomnia and insomnia are outlined in this review. Keywords: Hypersomnia, Insomnia, REM behavior International Journal of Head and Neck Surgery (2019): 10.5005/jp-journals-10001-1362 INTRODUCTION Department of Neurology and Sleep Disorder, Cleveland Clinic, Abu Sleep disorders are becoming increasingly common in this modern Dhabi, United Arab Emirates era, resulting from several lifestyle changes. These complaints may Corresponding Author: Preeti Devnani, Department of Neurology present excessive daytime sleepiness, lack of sleep or impaired and Sleep Disorder, Cleveland Clinic, Abu Dhabi, United Arab Emirates, quality, sleep related breathing disorders, circadian rhythm disorder e-mail: [email protected] misalignment and abnormal sleep-related movement disorders.1 How to cite this article: Devnani P. Sleep Disorders. Int J Head Neck They are associated with impaired daytime functioning, Surg 2019;10(1):4–8. increased risk of cardiovascular and cerebrovascular disease, poor Source of support: Nil glycemic control, risk of cognitive decline and impaired immunity Conflict of interest: None impacting overall morbidity and mortality. Diagnosis of sleep disorders is clinical in many scenarios, The following circadian rhythm sleep–wake disorders adapted polysomnography is a gold standard for further evaluation of from the ICSD-3: intrinsic sleep disorder such as obstructive sleep apnea (OSA) • Delayed sleep–wake phase disorder and periodic limb movement disorder (PLMD).
    [Show full text]
  • Original Articles
    ORIGINAL ARTICLES Improvement in Cataplexy and Daytime Somnolence in Narcoleptic Patients with Venlafaxine XR Administration Rafael J. Salin-Pascual, M.D., Ph.D. Narcoleptic patients have been treated with stimulants for sleep attacks as well as day- time somnolence, without effects on cataplexy, while this symptoms has been treated with antidepressants, that do not improve daytime somnolence or sleep attacks. Venlafaxine inhibits the reuptake of norepinephrine, serotonin, and to lesser extent dopamine, and also suppressed REM sleep. Because some of the symptoms of nar- colepsy may be related to REM sleep deregulation, venlafaxine was studied in this sleep disorder. Six narcoleptic patients were studied, they were drug-free and all of them had daytime somnolence and cataplexy attacks. They underwent the following sleep proce- dure: one acclimatization night, one baseline night, followed by multiple sleep latency test. After two days of the sleep protocol, patients received 150 mg of venlafaxine XR at 08:00 h. Two venlafaxine sleep nights recordings were performed. Patients were fol- lowed for two months with weekly visits for clinical evaluation. Sleep log and analog- visual scale for alertness and somnolence were performed on each visit. Venlafaxine XR was increase by the end of the first month to 300 mg/day. Sleep recordings showed that during venlafaxine XR two days acute administration the following findings: increase in wake time and sleep stage 1, while REM sleep time was reduced. No changes were observed in the rest of sleep architecture variables. Cataplexy attacks were reduced since the first week of venlafaxine administration. Daytime somnolence was reduced also, but until the 7th week and with 300 mg/day of venlafaxine XR administration.
    [Show full text]
  • The Co-Occurrence of Sexsomnia, Sleep Bruxism and Other Sleep Disorders
    Journal of Clinical Medicine Review The Co-Occurrence of Sexsomnia, Sleep Bruxism and Other Sleep Disorders Helena Martynowicz 1, Joanna Smardz 2, Tomasz Wieczorek 3, Grzegorz Mazur 1, Rafal Poreba 1, Robert Skomro 4, Marek Zietek 5, Anna Wojakowska 1, Monika Michalek 1 ID and Mieszko Wieckiewicz 2,* 1 Department of Internal Medicine, Occupational Diseases and Hypertension, Wroclaw Medical University, 50-367 Wroclaw, Poland; [email protected] (H.M.); [email protected] (G.M.); [email protected] (R.P.); [email protected] (A.W.); [email protected] (M.M.) 2 Department of Experimental Dentistry, Wroclaw Medical University, 50-367 Wroclaw, Poland; [email protected] 3 Department and Clinic of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland; [email protected] 4 Division of Respiratory Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5A2, Canada; [email protected] 5 Department of Periodontology, Wroclaw Medical University, 50-367 Wroclaw, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-660-47-87-59 Received: 3 August 2018; Accepted: 19 August 2018; Published: 23 August 2018 Abstract: Background: Sleep sex also known as sexsomnia or somnambulistic sexual behavior is proposed to be classified as NREM (non-rapid eye movement) parasomnia (as a clinical subtype of disorders of arousal from NREM sleep—primarily confusional arousals or less commonly sleepwalking), but it has also been described in relation to REM (rapid eye movement) parasomnias. Methods: The authors searched the PubMed database to identify relevant publications and present the co-occurrence of sexsomnia and other sleep disorders as a non-systematic review with case series.
    [Show full text]
  • Circadian Rhythm Sleep Disorders and Narcolepsy
    TALK FOR NARCOLEPSY NETWORK CONFERENCE 2013: Circadian Rhythm Sleep Disorders and Narcolepsy Note: The slides for this talk may be viewed at http://www.circadiansleepdisorders.org/docs/talks/NNconf2013talkSlides.pdf . Slides with audio of the talk are at http://youtu.be/i70SqjCr-jY . I. Introduction [title slide] A. Hello Hi. I’m Peter Mansbach, and I’m president of Circadian Sleep Disorders Network. I’m really glad for this opportunity to talk about circadian sleep disorders, and also about possible connections with narcolepsy. B. Disclaimer Let me start by saying I am not a medical doctor. I don’t diagnose, and I don’t treat. C. Why should the narcolepsy community care? [Overview slide] The various sleep disorders overlap. I have DSPS, but I have some of the same symptoms as narcolepsy. And many of you have symptoms of DSPS. Diagnoses are fuzzy too, and in some cases another sleep disorder may be secondary or even dominant. I’ll talk more about this later. D. Intro How many of you have trouble waking up in the morning? How many of you like to stay up late? II. Circadian Rhythm Sleep Disorders A. What are circadian rhythms? [slide] 1. General Circadian means "approximately a day". Circadian rhythms are processes in living organisms which cycle daily. They are produced internally in all living things. They are also referred to as the body clock. 2. In Humans Humans have internal cycles lasting on average about 24 hours and 10 minutes, though the length varies from person to person. (Early experiments seemed to show a cycle of about 25 hours, and this still gets quoted, but it is now known to be incorrect.
    [Show full text]
  • A Comparison of Idiopathic Hypersomnia and Narcolepsy-Cataplexy Using Self Report Measures and Sleep Diary Data
    57676ournal ofNeurology, Neurosurgery, and Psychiatry 1996;60:576-578 SHORT REPORT J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.60.5.576 on 1 May 1996. Downloaded from A comparison of idiopathic hypersomnia and narcolepsy-cataplexy using self report measures and sleep diary data Dorothy Bruck, J D Parkes Abstract Published data comparing patients with IH Eighteen patients with idiopathic hyper- and patients with NLS outside the sleep labo- somnia (IH) were compared with 50 ratory are scarce. Using self report question- patients with the narcoleptic syndrome of naires and sleep diary data our aim was to cataplexy and daytime sleepiness (NLS) determine the extent of group differences and using self report questionnaires and a which variables best discriminated between IH diary of sleep/wake patterns. The IH and NLS. group reported more consolidated noc- turnal sleep, a lower propensity to nap, greater refreshment after naps, and a Patients and methods greater improvement in excessive day- DIAGNOSTIC CRITERIA time sleepiness since onset than the NLS Idiopathic hypersomnia group. In IH, the onset of excessive day- Patients were selected with a complaint of time sleepiness was predominantly asso- excessive daytime sleepiness without cataplexy ciated with familial inheritance or a viral and with no evidence of any medical, psycho- illness. Two variables-number of logical, drug related, or respiratory disorder. reported awakenings during nocturnal All patients met diagnostic criteria ascertained sleep and the reported change in sleepi- from questionnaire responses: Epworth sleepi- ness since onset-provided maximum ness scale score8 > 13; duration of excessive discrimination between the IH and NLS daytime sleepiness > five years, profile of groups.
    [Show full text]
  • Narcolepsy-1111 28/11/11 9:15 PM Page 1
    SHF-Narcolepsy-1111 28/11/11 9:15 PM Page 1 Narcolepsy Important Things to Know About Narcolepsy • It is a disorder of excessive daytime sleepiness • It may have other symptoms that involve a loss of muscle function • Symptoms can be treated • It can occur at any age but often starts in early adulthood • Diagnosis is best done by a sleep specialist or neurologist What is narcolepsy? hallucinations. You may see or hear things that are not really there, especially if you are drowsy. Narcolepsy is a chronic neurological disorder of excessive daytime sleepiness. It may occur with other symptoms What causes narcolepsy? such as cataplexy, sleep paralysis and hallucinations. • All people with narcolepsy have excessive drowsiness. The part of the brain which controls falling asleep You may have a lack of energy. Strong urges to nap functions abnormally. During the day when normally can happen at any time of the day. Naps might last for awake and active, you might fall asleep with little minutes or up to an hour or more. After a nap you warning, rapidly going into a stage of sleep called Rapid may be alert for several hours. While this may happen Eye Movement (or REM) sleep. During normal REM sleep every day it is not because you aren’t sleeping enough there is both dreaming and temporary loss of muscle at night. tone. With the shift to REM sleep in narcolepsy, there might be hallucinations, cataplexy and sleep paralysis. It • Cataplexy is a sudden loss of muscle function while is thought that narcolepsy is related to lack of a brain conscious.
    [Show full text]
  • Clinical Guide for Sleep Specialists: Diagnosing Narcolepsy
    CLINICIAN GUIDE 1 This brochure can help you: Table of Contents RECOGNIZE Narcolepsy Overview..................................................................... 4 possible manifestations of excessive daytime sleepiness, Narcolepsy Symptoms.................................................................... 5 1-3 the cardinal symptom of narcolepsy Pathophysiology of Narcolepsy.................................................. 6 SCREEN Neurobiology of Normal Wakefulness...................................... 6 all patients with manifestations of excessive daytime sleepiness Pathophysiology of Narcolepsy................................................... 6 for narcolepsy using validated screening tools4-7 Recognizing Potential Narcolepsy Patients............................. 8 DIAGNOSE Recognizing Excessive Daytime Sleepiness........................... 8 narcolepsy through a complete clinical interview Recognizing Cataplexy................................................................... 9 and sleep laboratory testing1 Screening Your Patients................................................................ 10 Epworth Sleepiness Scale.............................................................. 10 Swiss Narcolepsy Scale...................................................................11 Diagnosing Narcolepsy..................................................................12 Clinical Interview............................................................................... 12 Sleep Laboratory Testing..............................................................
    [Show full text]
  • Kleine-Levin Syndrome: a Review
    Nature and Science of Sleep Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Kleine-Levin syndrome: a review Mitchell G Miglis Abstract: Kleine-Levin syndrome is a recurrent hypersomnia associated with symptoms of Christian Guilleminault hyperphagia, hypersexuality, and cognitive impairment. This article reviews the current available research and describes common clinical symptoms, differential diagnosis, and acceptable workup Stanford University Sleep Medicine Division, Stanford Outpatient Medical and treatment. Although deficits have traditionally been thought to resolve between episodes, Center, Redwood City, CA, USA functional imaging studies and long-term neuropsychological testing in select patients have recently challenged this notion. This may suggest that Kleine-Levin syndrome is not as benign as previously considered. Keywords: Kleine-Levin syndrome, hypersomnia, adolescent sleep disorder, hypersexuality Introduction Kleine-Levin syndrome is a recurrent hypersomnia characterized by episodes of hypersomnia separated by intervening periods of normal behavior. In addition to hypersomnia, at least one of the following symptoms must be present: cognitive or mood disturbances, hyperphagia with compulsive eating, hypersexuality, or abnormal behavior such as irritability, aggression, or personality changes (Table 1). Kleine-Levin syndrome was first described by Kleine in 1925 and elaborated on by Levin in 1936, but it was Critchley and Hoffman who further defined the syndrome in 1942 and gave it its eponym.1 In their classic paper “The Syndrome of Periodic Somnolence and Morbid Hunger”1 they describe the cases of two men in their 20s who developed hypersomnia and hyperphagia, with symptoms lasting days to weeks at a time and recurring every few months.
    [Show full text]
  • Kleine-Levin Syndrome: a Systematic Study of 108 Patients
    Kleine–Levin Syndrome: A Systematic Study of 108 Patients Isabelle Arnulf, MD, PhD,1,2 Ling Lin, MD, PhD,1 Nathan Gadoth, MD,3 Jennifer File, DO,1 Michel Lecendreux, MD,2 Patricia Franco, MD, PhD,2 Jamie Zeitzer, PhD,1 Betty Lo, PhD,1 Juliette H. Faraco, PhD,1 and Emmanuel Mignot, MD, PhD1 Objective: Kleine–Levin syndrome is a rare disorder characterized by relapsing-remitting episodes of hypersomnia, cognitive disturbances, and behavioral disturbances, such as hyperphagia and hypersexuality. Methods: We collected detailed clinical data and blood samples on 108 patients, 79 parent pairs, and 108 matched control subjects. We measured biological markers and typed human leukocyte antigen genes DR and DQ. Results: Novel predisposing factors were identified including increased birth and developmental problems (odds ratio, 6.5). Jewish heritage was overrepresented, and five multiplex families were identified. Human leukocyte antigen typing was unre- markable. Patients were 78% male (mean age at onset, 15.7 Ϯ 6.0 years), averaged 19 episodes of 13 days, and were incapac- itated 8 months over 14 years. The disease course was longer in men, in patients with hypersexuality, and when onset was after age 20. During episodes, all patients had hypersomnia, cognitive impairment, and derealization; 66% had megaphagia; 53% reported hypersexuality (principally men); and 53% reported a depressed mood (predominantly women). Patients were remark- ably similar to control subjects between episodes regarding sleep, mood, and eating attitude, but had increased body mass index. We found marginal efficacy for amantadine and mood stabilizers, but found no increased family history for neuropsychiatric disorders. Interpretation: The similarity of the clinical and demographic features across studies strongly suggests that Kleine–Levin syn- drome is a genuine disease entity.
    [Show full text]
  • CSF Hypocretin-1 Levels in Narcolepsy, Kleine-Levin Syndrome
    1667 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.74.12.1667 on 24 November 2003. Downloaded from PAPER CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions Y Dauvilliers, CR Baumann, B Carlander, M Bischof, T Blatter, M Lecendreux, F Maly, A Besset, J Touchon, M Billiard, M Tafti, CL Bassetti ............................................................................................................................... J Neurol Neurosurg Psychiatry 2003;74:1667–1673 Objective: To determine the role of CSF hypocretin-1 in narcolepsy with and without cataplexy, Kleine- Levin syndrome (KLS), idiopathic and other hypersomnias, and several neurological conditions. Patients: 26 narcoleptic patients with cataplexy, 9 narcoleptic patients without cataplexy, 2 patients with abnormal REM-sleep-associated hypersomnia, 7 patients with idiopathic hypersomnia, 2 patients with post-traumatic hypersomnia, 4 patients with KLS, and 88 patients with other neurological disorders. See end of article for Results: 23 patients with narcolepsy-cataplexy had low CSF hypocretin-1 levels, while one patient had a authors’ affiliations normal hypocretin level (HLA-DQB1*0602 negative) and the other two had intermediate levels (familial ....................... forms). One narcoleptic patient without cataplexy had a low hypocretin level. One patient affected with Correspondence to: post-traumatic hypersomnia had intermediate hypocretin levels. The KLS patients had normal hypocretin Dr Yves Dauvilliers, Service levels while asymptomatic, but one KLS patient (also affected with Prader-Willi syndrome) showed a de Neurologie B, Hoˆpital Gui-de-Chauliac, twofold decrease in hypocretin levels during a symptomatic episode. Among the patients without 80 avenue Augustin Fliche, hypersomnia, two patients with normal pressure hydrocephalus and one with unclear central vertigo had 34295 Montpellier cedex intermediate levels.
    [Show full text]
  • Sleep Disorders in Wilson's Disease
    Current Neurology and Neuroscience Reports (2019) 19:84 https://doi.org/10.1007/s11910-019-1001-4 SLEEP (M. THORPY AND M. BILLIARD, SECTION EDITORS) Sleep Disorders in Wilson’s Disease Valérie Cochen De Cock1,2 & France Woimant3,4 & Aurélia Poujois3,5 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Purpose of Review We aimed to review the sleep disorders described in Wilson’s disease (WD), focusing on their mechanisms and treatments. Recent Findings REM sleep behavior disorder or sleepiness can be warning signs of future WD. These early symptoms may significantly reduce the time to WD diagnosis. Early anti-copper therapies (chelators or zinc salts), reducing copper accumulation in the brain and though saving brain tissue, can allow the complete disappearance of these sleep disorders and of course improve the other symptoms of WD. Summary Insomnia, restless legs syndrome (RLS), daytime sleepiness, cataplexy, and REM sleep behavior disorder (RBD) are present in WD and should be explored with video polysomnography and multiple sleep latency test. Suggested immobilization test could be useful in the diagnosis of RLS in WD. Motor and non-motor symptoms, dysautonomic dysfunctions, drugs, and lesions of the circuits regulating wake and sleep may be involved in the mechanisms of these sleep abnormalities. Adapted treatments should be proposed. Keywords Wilson’sdisease . REM sleep behavior disorder . Sleepiness . Cataplexy . Insomnia . Restless legs syndrome Introduction release into the bile, resulting in accumulation that leads to hepatocytes death [1, 2•, 3]. The spectrum of the liver disease Wilson’s disease (WD) is a rare autosomal recessive disorder is wide, from slight variations of liver enzymes to fulminant that leads to a copper overload, mainly in the liver and the hepatitis or compensated cirrhosis.
    [Show full text]